Abstract | BACKGROUND: Micro-dispersed oxidized cellulose, already used for hemostasis, might be helpful for introduction of an antimicrobial drug. AIM: To examine the effect of topically applied gentamicin attached to a new biodegradable carrier formed by micro-dispersed oxidized cellulose in microfiber and nanofiber form for treatment of acute wound infection and to assess the influence of this carrier on healing. MATERIALS AND METHODS: A model of a full-thickness infected dermal wound was created in 12 female domestic pigs. The effectiveness of topical gentamicin delivered with micro-dispersed oxidized cellulose carrier was tested in acute wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa, or Escherichia coli. RESULTS: The effectiveness of nanofiber micro-dispersed oxidized cellulose with gentamicin was proved according to culture findings. When assessed macroscopically, 100% of wounds treated by the nanofiber product had no signs of local infection. When microfiber micro-dispersed oxidized cellulose was used, cultures demonstrated residual bacteria in 94.4% of treated incisions despite the absence of clinically recognized infection. CONCLUSIONS: Micro-dispersed oxidized cellulose carrier with a sufficient concentration of an attached antibiotic appears to be effective for the treatment of full-thickness skin infections. The positive influence of the product on the healing of a dermal incision was shown, and a good hemostatic effect was confirmed.
|
Authors | Petr Lochman, Michal Plodr, Jirí Páral, Karel Smejkal |
Journal | Surgical infections
(Surg Infect (Larchmt))
Vol. 11
Issue 1
Pg. 29-32
(Feb 2010)
ISSN: 1557-8674 [Electronic] United States |
PMID | 20163259
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents, Local
- Cellulose, Oxidized
- Drug Carriers
- Gentamicins
|
Topics |
- Administration, Topical
- Animals
- Anti-Infective Agents, Local
(therapeutic use)
- Bacterial Infections
(drug therapy)
- Cellulose, Oxidized
(administration & dosage)
- Disease Models, Animal
- Drug Carriers
(administration & dosage)
- Escherichia coli
(drug effects, isolation & purification)
- Female
- Gentamicins
(therapeutic use)
- Nanofibers
(administration & dosage)
- Pseudomonas aeruginosa
(drug effects, isolation & purification)
- Staphylococcus aureus
(drug effects, isolation & purification)
- Swine
- Treatment Outcome
- Wound Healing
- Wound Infection
(drug therapy)
|